A Multicenter,Investigator-blinded,Randomized, Comparative Study to Evaluate the Efficacy and Safety of Oral NXL103 Versus Oral Linezolid in the Treatment of Complicated Skin and Skin Structure Infections (cSSSI).
Phase of Trial: Phase II
Latest Information Update: 03 Sep 2015
At a glance
- Drugs Linopristin/flopristin (Primary) ; Linezolid
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Novexel
- 07 Nov 2009 Additional location (Guatemala and USA) identified as reported by ClinicalTrials.gov.
- 06 Nov 2009 Status changed from not yet recruiting to recruiting, according to a Novexel media release.
- 08 Aug 2009 New trial record